About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Sarcomatoid Carcinoma of Prostate: A Rare Entity
PHILLIPS Adekoyejo Abiodun1, DARAMOLA Adetola1, ANUNOBI Charles1, TIJANI Kehinde Habbeb2, MOMOH Martins1
Department of Anatomical and Molecular Pathology1 & Department of Surgery2, Lagos University Teaching Hospital, Idi-Araba, Lagos. PMB 12003, Lagos, Nigeria.
Corresponding Author:
Dr. DARAMOLA Adetola
Email: aodaramola@unilag.edu.ng
Received: 10-SEP-201 Accepted: 08-JAN-2014 Published Online: 25-JAN-2014
DOI: http://dx.doi.org/10.17659/01.2014.0009
Abstract
Sarcomatoid carcinoma is an aggressive, rare malignancy of the prostate with less than 100 reported cases worldwide. A 60 year old male presented in our surgical outpatient department, with symptoms of bladder outlet obstruction and a prostate specific antigenof 0.94 ng/L. A clinical assessment of benign prostatic hypertrophy was made and prostatectomy was done. The specimen received in our laboratory consisted of two firm, grayish white nodular masses with variegated haemorrhagic surfaces. Histology revealed a biphasic tumor with a predominately spindle cell component (80%) as well as clusters and nests of small undifferentiated cells. Also seen were nests of a well differentiated keratinizing squamous cell carcinoma which were EMA positive. A few of the small undifferentiated cells and stromal cells were also EMA positive but negative for desmin. About 40% of cells in stained sections were positive for Ki67. A diagnosis of sarcomatoid carcinoma of the prostate with a Gleason score of 10 was made. 
Keywords : Prostatic hyperplasia, Prostate-Specific antigen, Carcinoma, Squamous cell, Desmin.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports

abortion pill online

Secure abortion pill tablets. There he could simply order pill for abortion online generic.There we could simply order generic site.
Last updated on Apr 05, 2024